The actor Jeff Bridges 75, shared news about your health. The star of “The Great Lebowski “He said he’s” feeling good “almost five years since he was diagnosed with lymphoma.
“Some things, it’s hard to say whether it’s cancer, Covid or just age,” he said in an interview with People magazine, saying he is in memory problems he believes to be Covid-19.
“I can’t feel smells,” said Bridges. Both memory failure and smell loss are symptoms of a long infection by coronavirus.
In October 2020, the actor shared his cancer diagnosis on his X profile. “Although it is a serious illness, I feel lucky to have a great team of doctors and a good prognosis,” Bridges wrote at the time. “I’m starting the treatment and I will keep them up to date on my recovery.”
The following year, he shared on his personal website that the cancer mass shrunk to the size “of a marble”.
Jeff Bridges also said he was recovering from a serious covid-19 infection at the time, believing he was infected with the virus after being exposed where he was receiving chemotherapy treatment.
Although he assured that his symptoms of coronaviruses were “behind,” he wrote that “my dance with Covid makes my cancer look easy.”
“Covid gave me a good beating, but I’m doubly vaccinated and feeling much better now,” wrote Bridges. “Although I had moments of tremendous pain… coming close to heavenly gates, I was generally happy and happy most of the time. This contact with mortality brought me a true gift: life is brief and beautiful.”
The Oscar winner recently completed his FX series, “The old man “And is preparing to appear in the third part of the franchise“Tron “It will be released later this year.
*With information from Sandra Gonzalez, from CNN
This content was originally published in Jeff Bridges says that Covid’s case makes cancer appear “easy” on CNN Brazil.
Source: CNN Brasil
I’m Robert Neff, a professional writer and editor. I specialize in the entertainment section, providing up-to-date coverage on the latest developments in film, television and music. My work has been featured on World Stock Market and other prominent publications.
